Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
First Claim
1. A therapeutic preparation comprising PTH or PTH analogue, the preparation shaped as a solid tissue penetrating member shaped and configured to penetrate and be inserted into an intestinal wall after oral ingestion, wherein upon insertion, the preparation releases PTH or PTH analogue into the blood stream from the intestinal wall by degradation of the tissue penetrating member to achieve a Cmax in a shorter time period than a time period to achieve a Cmax for an extravascularly injected dose of PTH or PTH analogue, wherein the tissue penetrating member has sufficient stiffness to be advanced completely into the intestinal wall by the application of a force to the tissue penetrating member.
2 Assignments
0 Petitions
Accused Products
Abstract
Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Many embodiments provide a swallowable device for delivering the agents. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade to release the drug into the bloodstream to produce a therapeutic effect. The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
189 Citations
23 Claims
- 1. A therapeutic preparation comprising PTH or PTH analogue, the preparation shaped as a solid tissue penetrating member shaped and configured to penetrate and be inserted into an intestinal wall after oral ingestion, wherein upon insertion, the preparation releases PTH or PTH analogue into the blood stream from the intestinal wall by degradation of the tissue penetrating member to achieve a Cmax in a shorter time period than a time period to achieve a Cmax for an extravascularly injected dose of PTH or PTH analogue, wherein the tissue penetrating member has sufficient stiffness to be advanced completely into the intestinal wall by the application of a force to the tissue penetrating member.
-
23. A therapeutic preparation comprising PTH or PTH analogue, the preparation shaped as a solid tissue penetrating member shaped and configured to penetrate and be inserted into an intestinal wall after oral ingestion, wherein upon insertion, the preparation releases PTH or PTH analogue into the blood stream from the intestinal wall by degradation of the tissue penetrating member to achieve a t1/2 that is greater than a t1/2 for orally ingested PTH or PTH analogue that is not inserted into the intestinal wall, wherein the tissue penetrating member has sufficient stiffness to be advanced completely into the intestinal wall by the application of a force to the tissue penetrating member.
Specification